| Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2010 Financial Results - PR Newswire (press release) |
|
|
PR Newswire (press release)The Phase 3 clinical program of Zerenex in the treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being ... read more |